AMLN
AMLN
$27.96
*
2.16
negative
8.37%

*Data as of May 25, 2012   | Amylin Pharmaceuticals, Inc. | Industry: Consumer Durables | HQ: California, United States
 
 

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

 Save stocks for next time
 |  Sponsored

AMLN News Headlines

Share |


   


Lilly's GLP-1 Agonist Delivers - Analyst Blog
5/23/2012 7:39:01 PM - Zacks.com

Did You Buy These Stocks?
5/23/2012 8:50:00 AM - RTT News

Revenues Skyrocket at Merged Alkermes - Analyst Blog
5/18/2012 5:10:01 PM - Zacks.com

Company News for May 16, 2012 - Corporate Summary
5/16/2012 10:06:01 AM - Zacks.com

Hot Biotech Stocks Traded by Hedge Funds in First Quarter
5/16/2012 7:10:00 AM - TheStreet

Amylin Pharma Hold Annual Meeting At 12:00 PM ET
5/15/2012 11:03:00 AM - RTT News

Amylin Pharma To Present At Deutsche Bank Conference; Webcast At 2:10 PM ET
5/7/2012 1:13:00 PM - RTT News

Amylin Pharma Q1 Loss Widens
4/26/2012 9:15:00 AM - RTT News

Icahn: Suit Against Amylin Dropped After Talks With CEO
4/25/2012 2:37:00 PM - Dow Jones Business News

Amylin Pharmaceuticals Inc. (AMLN) Has Taken Out The Highs Of The Morning
4/23/2012 10:26:00 AM - RTT News

Pre-Market Most Active for Apr 23, 2012 : BAC, RDEA, SNY, TOT, SIRI, NOK, ERIC, WMT, AMLN, RDS/A, QQQ, AAPL
4/23/2012 8:39:57 AM - NASDAQ.com News

Reports: Amylin Seeks Buyers
4/23/2012 12:08:00 AM - RTT News

UPDATE: FDA Is Asked To Remove Novo Nordisk Diabetes Drug From Market
4/19/2012 6:17:00 PM - Dow Jones Business News

FDA Is Asked To Remove Novo Nordisk Diabetes Drug From Market
4/19/2012 1:38:00 PM - Dow Jones Business News

Carl Icahn Pressurizes Amylin With Lawsuit To Pursue Sale Of Company
4/9/2012 9:57:00 PM - RTT News

Amylin Completes BLA Submission - Analyst Blog
4/9/2012 3:42:00 PM - Zacks.com

Icahn Files Lawsuit Against Amylin To Force Nomination Extension
4/9/2012 12:53:00 PM - Dow Jones Business News

2nd UPDATE: Icahn Tells Amylin To Pursue Sale, Seeks Proxy Extension
4/4/2012 4:03:00 PM - Dow Jones Business News

UPDATE: Icahn Tells Amylin To Pursue Sale, Seeks Proxy Extension
4/4/2012 9:58:00 AM - Dow Jones Business News

Amylin Pharmaceuticals Completes Submission Of BLA For Metreleptin To FDA
4/3/2012 8:45:00 AM - RTT News

The Zacks Analyst Blog Highlights: Amylin Pharmaceutical, Bristol-Myers Squibb, Eli Lilly, Express Scripts and Medco Health Solutions - Press Releases
3/30/2012 9:19:43 AM - Zacks.com

Amylin Shoots Up on Takeover Rumors - Analyst Blog
3/29/2012 4:15:01 PM - Zacks.com

Company News for March 29, 2012 - Corporate Summary
3/29/2012 10:06:01 AM - Zacks.com

Amylin Pharmaceuticals Inc. (AMLN) Broke Out To A New High On BMY Rumors
3/29/2012 6:30:00 AM - RTT News

Amylin Shares Jump On Report Of Rejected Bristol-Myers Offer
3/28/2012 6:17:00 PM - RTT News